サマリー

クリンダマイシンは、リンコマイシン系の抗生物質で、嫌気性細菌の感染症だけでなく、マラリアなどの原虫類の感染症の治療にもよく使われます。

市場分析とインサイトクリンダマイシンの世界市場
クリンダマイシンの世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にXX百万米ドルに達すると予測されています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のクリンダマイシン市場で利用可能な主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、収益面でのクリンダマイシン世界市場の全体的なサイズを含む、検証された信頼できる市場予測にアクセスすることができます。
全体として、本レポートは、プレイヤーが競合他社に対して優位に立ち、世界のクリンダマイシン市場で永続的な成功を収めるために利用できる効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のクリンダマイシン市場を詳細に調査するために、ユニークで業界最高の調査・分析手法を採用しました。

世界のクリンダマイシンの範囲と市場規模
クリンダマイシン市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のクリンダマイシン市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
経口
注射剤
準備段階

用途別セグメント
陽性菌による感染症
嫌気性菌に起因する感染症

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
グレンマーク製薬
プラスコ・ラボラトリーズ
バレント・ファーマシューティカルズ
ダウ・ファーマシューティカルズ・サイエンシズ(Dow PharmaceuticalsSciences)
バウシュ・ヘルス
ダーミックラボラトリーズ
アンギータ・ファーマ
アポテックス・コーポレーション
オーロ・ファーマ
アバンストラ社
フィジシャンズ・トータル・ケア
ファルマシア・アップジョン社
珠海聯邦製薬
中山支店雲南工場製薬
山東方明製薬グループ
蘇州第四製薬工場
金太陽製薬 重慶慶瑞製薬集団
重慶慶瑞薬業有限公司
黒龍江省天健製薬
江蘇中丹製薬
河北華諾
深圳大福製薬

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clindamycin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.2.4 Preparation
1.3 Market by Application
1.3.1 Global Clindamycin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Infectious Diseases Caused By Positive Bacteria
1.3.3 Infectious Diseases Caused By Anaerobe
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Clindamycin Market Perspective (2016-2027)
2.2 Clindamycin Growth Trends by Regions
2.2.1 Clindamycin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Clindamycin Historic Market Share by Regions (2016-2021)
2.2.3 Clindamycin Forecasted Market Size by Regions (2022-2027)
2.3 Clindamycin Industry Dynamic
2.3.1 Clindamycin Market Trends
2.3.2 Clindamycin Market Drivers
2.3.3 Clindamycin Market Challenges
2.3.4 Clindamycin Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Clindamycin Players by Revenue
3.1.1 Global Top Clindamycin Players by Revenue (2016-2021)
3.1.2 Global Clindamycin Revenue Market Share by Players (2016-2021)
3.2 Global Clindamycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Clindamycin Revenue
3.4 Global Clindamycin Market Concentration Ratio
3.4.1 Global Clindamycin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clindamycin Revenue in 2020
3.5 Clindamycin Key Players Head office and Area Served
3.6 Key Players Clindamycin Product Solution and Service
3.7 Date of Enter into Clindamycin Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Clindamycin Breakdown Data by Type
4.1 Global Clindamycin Historic Market Size by Type (2016-2021)
4.2 Global Clindamycin Forecasted Market Size by Type (2022-2027)

5 Clindamycin Breakdown Data by Application
5.1 Global Clindamycin Historic Market Size by Application (2016-2021)
5.2 Global Clindamycin Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Clindamycin Market Size (2016-2027)
6.2 North America Clindamycin Market Size by Type
6.2.1 North America Clindamycin Market Size by Type (2016-2021)
6.2.2 North America Clindamycin Market Size by Type (2022-2027)
6.2.3 North America Clindamycin Market Size by Type (2016-2027)
6.3 North America Clindamycin Market Size by Application
6.3.1 North America Clindamycin Market Size by Application (2016-2021)
6.3.2 North America Clindamycin Market Size by Application (2022-2027)
6.3.3 North America Clindamycin Market Size by Application (2016-2027)
6.4 North America Clindamycin Market Size by Country
6.4.1 North America Clindamycin Market Size by Country (2016-2021)
6.4.2 North America Clindamycin Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Clindamycin Market Size (2016-2027)
7.2 Europe Clindamycin Market Size by Type
7.2.1 Europe Clindamycin Market Size by Type (2016-2021)
7.2.2 Europe Clindamycin Market Size by Type (2022-2027)
7.2.3 Europe Clindamycin Market Size by Type (2016-2027)
7.3 Europe Clindamycin Market Size by Application
7.3.1 Europe Clindamycin Market Size by Application (2016-2021)
7.3.2 Europe Clindamycin Market Size by Application (2022-2027)
7.3.3 Europe Clindamycin Market Size by Application (2016-2027)
7.4 Europe Clindamycin Market Size by Country
7.4.1 Europe Clindamycin Market Size by Country (2016-2021)
7.4.2 Europe Clindamycin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Clindamycin Market Size (2016-2027)
8.2 Asia-Pacific Clindamycin Market Size by Type
8.2.1 Asia-Pacific Clindamycin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Clindamycin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Clindamycin Market Size by Type (2016-2027)
8.3 Asia-Pacific Clindamycin Market Size by Application
8.3.1 Asia-Pacific Clindamycin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Clindamycin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Clindamycin Market Size by Application (2016-2027)
8.4 Asia-Pacific Clindamycin Market Size by Region
8.4.1 Asia-Pacific Clindamycin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Clindamycin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Clindamycin Market Size (2016-2027)
9.2 Latin America Clindamycin Market Size by Type
9.2.1 Latin America Clindamycin Market Size by Type (2016-2021)
9.2.2 Latin America Clindamycin Market Size by Type (2022-2027)
9.2.3 Latin America Clindamycin Market Size by Type (2016-2027)
9.3 Latin America Clindamycin Market Size by Application
9.3.1 Latin America Clindamycin Market Size by Application (2016-2021)
9.3.2 Latin America Clindamycin Market Size by Application (2022-2027)
9.3.3 Latin America Clindamycin Market Size by Application (2016-2027)
9.4 Latin America Clindamycin Market Size by Country
9.4.1 Latin America Clindamycin Market Size by Country (2016-2021)
9.4.2 Latin America Clindamycin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Clindamycin Market Size (2016-2027)
10.2 Middle East & Africa Clindamycin Market Size by Type
10.2.1 Middle East & Africa Clindamycin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Clindamycin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Clindamycin Market Size by Type (2016-2027)
10.3 Middle East & Africa Clindamycin Market Size by Application
10.3.1 Middle East & Africa Clindamycin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Clindamycin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Clindamycin Market Size by Application (2016-2027)
10.4 Middle East & Africa Clindamycin Market Size by Country
10.4.1 Middle East & Africa Clindamycin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Clindamycin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Glenmark Pharmaceuticals
11.1.1 Glenmark Pharmaceuticals Company Details
11.1.2 Glenmark Pharmaceuticals Business Overview
11.1.3 Glenmark Pharmaceuticals Clindamycin Introduction
11.1.4 Glenmark Pharmaceuticals Revenue in Clindamycin Business (2016-2021)
11.1.5 Glenmark Pharmaceuticals Recent Development
11.2 Prasco Laboratories
11.2.1 Prasco Laboratories Company Details
11.2.2 Prasco Laboratories Business Overview
11.2.3 Prasco Laboratories Clindamycin Introduction
11.2.4 Prasco Laboratories Revenue in Clindamycin Business (2016-2021)
11.2.5 Prasco Laboratories Recent Development
11.3 Valent Pharmaceuticals
11.3.1 Valent Pharmaceuticals Company Details
11.3.2 Valent Pharmaceuticals Business Overview
11.3.3 Valent Pharmaceuticals Clindamycin Introduction
11.3.4 Valent Pharmaceuticals Revenue in Clindamycin Business (2016-2021)
11.3.5 Valent Pharmaceuticals Recent Development
11.4 Dow PharmaceuticalsSciences
11.4.1 Dow PharmaceuticalsSciences Company Details
11.4.2 Dow PharmaceuticalsSciences Business Overview
11.4.3 Dow PharmaceuticalsSciences Clindamycin Introduction
11.4.4 Dow PharmaceuticalsSciences Revenue in Clindamycin Business (2016-2021)
11.4.5 Dow PharmaceuticalsSciences Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Details
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Clindamycin Introduction
11.5.4 Bausch Health Revenue in Clindamycin Business (2016-2021)
11.5.5 Bausch Health Recent Development
11.6 Dermik Laboratories
11.6.1 Dermik Laboratories Company Details
11.6.2 Dermik Laboratories Business Overview
11.6.3 Dermik Laboratories Clindamycin Introduction
11.6.4 Dermik Laboratories Revenue in Clindamycin Business (2016-2021)
11.6.5 Dermik Laboratories Recent Development
11.7 Angita Pharma
11.7.1 Angita Pharma Company Details
11.7.2 Angita Pharma Business Overview
11.7.3 Angita Pharma Clindamycin Introduction
11.7.4 Angita Pharma Revenue in Clindamycin Business (2016-2021)
11.7.5 Angita Pharma Recent Development
11.8 Apotex Corporation
11.8.1 Apotex Corporation Company Details
11.8.2 Apotex Corporation Business Overview
11.8.3 Apotex Corporation Clindamycin Introduction
11.8.4 Apotex Corporation Revenue in Clindamycin Business (2016-2021)
11.8.5 Apotex Corporation Recent Development
11.9 Auro Pharma
11.9.1 Auro Pharma Company Details
11.9.2 Auro Pharma Business Overview
11.9.3 Auro Pharma Clindamycin Introduction
11.9.4 Auro Pharma Revenue in Clindamycin Business (2016-2021)
11.9.5 Auro Pharma Recent Development
11.10 Avanstra Inc
11.10.1 Avanstra Inc Company Details
11.10.2 Avanstra Inc Business Overview
11.10.3 Avanstra Inc Clindamycin Introduction
11.10.4 Avanstra Inc Revenue in Clindamycin Business (2016-2021)
11.10.5 Avanstra Inc Recent Development
11.11 Physicians Total Care
11.11.1 Physicians Total Care Company Details
11.11.2 Physicians Total Care Business Overview
11.11.3 Physicians Total Care Clindamycin Introduction
11.11.4 Physicians Total Care Revenue in Clindamycin Business (2016-2021)
11.11.5 Physicians Total Care Recent Development
11.12 Pharmacia and Upjohn Company
11.12.1 Pharmacia and Upjohn Company Company Details
11.12.2 Pharmacia and Upjohn Company Business Overview
11.12.3 Pharmacia and Upjohn Company Clindamycin Introduction
11.12.4 Pharmacia and Upjohn Company Revenue in Clindamycin Business (2016-2021)
11.12.5 Pharmacia and Upjohn Company Recent Development
11.13 Zhuhai Lianbang Pharmaceutical
11.13.1 Zhuhai Lianbang Pharmaceutical Company Details
11.13.2 Zhuhai Lianbang Pharmaceutical Business Overview
11.13.3 Zhuhai Lianbang Pharmaceutical Clindamycin Introduction
11.13.4 Zhuhai Lianbang Pharmaceutical Revenue in Clindamycin Business (2016-2021)
11.13.5 Zhuhai Lianbang Pharmaceutical Recent Development
11.14 Zhongshan Branch Yunnan Plant Pharmaceutical
11.14.1 Zhongshan Branch Yunnan Plant Pharmaceutical Company Details
11.14.2 Zhongshan Branch Yunnan Plant Pharmaceutical Business Overview
11.14.3 Zhongshan Branch Yunnan Plant Pharmaceutical Clindamycin Introduction
11.14.4 Zhongshan Branch Yunnan Plant Pharmaceutical Revenue in Clindamycin Business (2016-2021)
11.14.5 Zhongshan Branch Yunnan Plant Pharmaceutical Recent Development
11.15 Shandong Fangming Pharmaceutical Group
11.15.1 Shandong Fangming Pharmaceutical Group Company Details
11.15.2 Shandong Fangming Pharmaceutical Group Business Overview
11.15.3 Shandong Fangming Pharmaceutical Group Clindamycin Introduction
11.15.4 Shandong Fangming Pharmaceutical Group Revenue in Clindamycin Business (2016-2021)
11.15.5 Shandong Fangming Pharmaceutical Group Recent Development
11.16 Suzhou No. 4 Pharmaceutical Factory
11.16.1 Suzhou No. 4 Pharmaceutical Factory Company Details
11.16.2 Suzhou No. 4 Pharmaceutical Factory Business Overview
11.16.3 Suzhou No. 4 Pharmaceutical Factory Clindamycin Introduction
11.16.4 Suzhou No. 4 Pharmaceutical Factory Revenue in Clindamycin Business (2016-2021)
11.16.5 Suzhou No. 4 Pharmaceutical Factory Recent Development
11.17 Golden Sun Pharmaceutical Chongqing Kerui Pharmaceutical Group
11.17.1 Golden Sun Pharmaceutical Chongqing Kerui Pharmaceutical Group Company Details
11.17.2 Golden Sun Pharmaceutical Chongqing Kerui Pharmaceutical Group Business Overview
11.17.3 Golden Sun Pharmaceutical Chongqing Kerui Pharmaceutical Group Clindamycin Introduction
11.17.4 Golden Sun Pharmaceutical Chongqing Kerui Pharmaceutical Group Revenue in Clindamycin Business (2016-2021)
11.17.5 Golden Sun Pharmaceutical Chongqing Kerui Pharmaceutical Group Recent Development
11.18 Chongqing Kerui Pharmaceutical Group
11.18.1 Chongqing Kerui Pharmaceutical Group Company Details
11.18.2 Chongqing Kerui Pharmaceutical Group Business Overview
11.18.3 Chongqing Kerui Pharmaceutical Group Clindamycin Introduction
11.18.4 Chongqing Kerui Pharmaceutical Group Revenue in Clindamycin Business (2016-2021)
11.18.5 Chongqing Kerui Pharmaceutical Group Recent Development
11.18 Heilongjiang Tianchen Pharmaceutical
.1 Heilongjiang Tianchen Pharmaceutical Company Details
.2 Heilongjiang Tianchen Pharmaceutical Business Overview
.3 Heilongjiang Tianchen Pharmaceutical Clindamycin Introduction
.4 Heilongjiang Tianchen Pharmaceutical Revenue in Clindamycin Business (2016-2021)
.5 Heilongjiang Tianchen Pharmaceutical Recent Development
11.20 Jiangsu Zhongdan Pharmaceutical
11.20.1 Jiangsu Zhongdan Pharmaceutical Company Details
11.20.2 Jiangsu Zhongdan Pharmaceutical Business Overview
11.20.3 Jiangsu Zhongdan Pharmaceutical Clindamycin Introduction
11.20.4 Jiangsu Zhongdan Pharmaceutical Revenue in Clindamycin Business (2016-2021)
11.20.5 Jiangsu Zhongdan Pharmaceutical Recent Development
11.21 Hebei Huanuo
11.21.1 Hebei Huanuo Company Details
11.21.2 Hebei Huanuo Business Overview
11.21.3 Hebei Huanuo Clindamycin Introduction
11.21.4 Hebei Huanuo Revenue in Clindamycin Business (2016-2021)
11.21.5 Hebei Huanuo Recent Development
11.22 Shenzhen Dafu Pharmaceutical
11.22.1 Shenzhen Dafu Pharmaceutical Company Details
11.22.2 Shenzhen Dafu Pharmaceutical Business Overview
11.22.3 Shenzhen Dafu Pharmaceutical Clindamycin Introduction
11.22.4 Shenzhen Dafu Pharmaceutical Revenue in Clindamycin Business (2016-2021)
11.22.5 Shenzhen Dafu Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details